Revolo Biotherapeutics
Tunde is currently the Chief Medical Officer of Veloxis Pharmaceuticals in North Carolina, the USA since August 2020. Prior to Veloxis, he was Senior Vice President and Chief Medical Officer at Mallinckrodt Pharmaceuticals. His career, which spans about 30 years in the industry, government, and academia, includes leadership roles at Boehringer Ingelheim Pharmaceutical Inc. and the US Food and Drug Administration (“FDA”). Tunde is a physician trained in Pulmonary and Critical Care Medicine.
This person is not in the org chart
This person is not in any offices
Revolo Biotherapeutics
Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.